Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leiomyosarcoma × Trabectedin × 1 year × Clear all

Sponsor

Conditions

Sarcoma 7 Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Recurrent High Grade Meningioma 1 Recurrence 1 Ovarian Neoplasms 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leiomyosarcoma Uterus 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1

Interventions

Doxorubicin 5 Specimen Handling 4 Gemcitabine 3 eribulin 2 Radiotherapy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Dacarbazine 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 sotigalimab 1 selinexor 1 ribociclib 1 regorafenib 1 pembrolizumab 1 pazopanib 1 olaratumab 1 liposomal doxorubicin 1 lenvatinib 1 futibatinib 1 durvalumab 1 dinutuximab 1 cemiplimab 1 cabozantinib 1 avelumab 1 anlotinib 1 abemaciclib 1 Zoledronic Acid 1 X-Rays 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡